A review on targeted therapies for lung cancer

A review on targeted therapies for lung cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Detalhes bibliográficos
Autor principal:	Ashraf, Anushey
Outros Autores:	Khan, Tanisha Tabassum Sayka
Formato:	Thesis
Idioma:	English
Publicado em:	Brac University 2023
Assuntos:	Lung cancer Antibodies Targeted therapy Vaccines Lung cancer > Treatment
Acesso em linha:	http://hdl.handle.net/10361/19353

Registos relacionados

Immunotherapy in the Management of Lung Cancer
Por: Tasnim, Humayra
Publicado em: (2022)

Potential of liposomes for the treatment of lung cancer- a review
Por: Mim, Shanzida
Publicado em: (2023)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
Por: Tania, Umme
Publicado em: (2023)

Molecules associated with the development of lung cancer
Por: Rahman, Adree, et al.
Publicado em: (2023)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
Por: Paul, Pulock
Publicado em: (2024)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
Por: Rahman, Tasnim
Publicado em: (2024)

A review on recent advances in drugs for lung cancer treatment
Por: Noor, Fouzia
Publicado em: (2024)

Protein biomarkers for Lung Cancer: a bioinformatic approach
Por: Jeba, Joynob
Publicado em: (2017)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
Por: Razna, Amrin Islam
Publicado em: (2019)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
Por: Flora, Sanzida Alam
Publicado em: (2024)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
Por: Pial, Sazia Afrin
Publicado em: (2018)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
Por: Zangmo, Thinley
Publicado em: (2024)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
Por: Hoque, Ismoth Ara
Publicado em: (2024)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
Por: Shabnam, Musharrat
Publicado em: (2018)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
Por: Bristy, Israt Zerin
Publicado em: (2021)

Targeted therapeutic options in the treatment of Breast Cancer
Por: Alam, Kazi Tasnuva
Publicado em: (2022)

Lung cancer detection and classification using machine learning
Por: Arefin, Mahbubul, et al.
Publicado em: (2023)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
Por: Das, Reshita
Publicado em: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
Por: Jahan, Nusrat
Publicado em: (2024)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
Por: Nandy, Aditi
Publicado em: (2022)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
Por: Mukti, Roushney Fatima, et al.
Publicado em: (2016)

Therapeutic prospective of targeting calcium homeostasis in cancer – a review
Por: Kamal, Tasnova
Publicado em: (2019)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
Por: Nahar, Kamrun
Publicado em: (2023)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
Por: Ratu, Tabassum
Publicado em: (2024)

A review on carbon nanotube: a new era in cancer diagnosis & therapy
Por: Parvez, Safi
Publicado em: (2023)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
Por: Meem, Manila
Publicado em: (2023)

A comprehensive review on drug repurposing in cancer treatment
Por: Sarkar, Onusree
Publicado em: (2024)

The impact of cell penetrating peptides in prospective cancer therapy: a review
Por: Nashrah, Zannatul
Publicado em: (2023)

Breast cancer therapy through Liposomal drug delivery system
Por: Ome, Nusrat Jahan
Publicado em: (2024)

Trend in approval of targeted biologics in the last two decades
Por: Siddika, Khadiza
Publicado em: (2024)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
Por: Hasan, Amit
Publicado em: (2024)

Current practice and approaches of immunotherapy in Cancer treatment
Por: Khondokar, Faiza
Publicado em: (2022)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
Por: Karim, Samia Binte
Publicado em: (2024)

Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
Por: Alam, Tahera
Publicado em: (2024)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
Por: Abir, Shifaty Nur
Publicado em: (2024)

A review paper on Nanotechnology based strategies in the treatment of cancer
Por: Rahman, Samia
Publicado em: (2022)

A review on potential of PARP inhibitors in the treatment of prostate cancer
Por: Islam, Saidul
Publicado em: (2022)

The uses of bacteria in cancer therapy
Por: Saha, Shimul, et al.
Publicado em: (2021)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
Por: Chakraborty, Anuradha
Publicado em: (2024)

Concepts and challenges of biosimilars to mitigate the oncology drug expenses
Por: Tania, Umme
Publicado em: (2021)